LINC01198: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01198

NCBI ID: G101929344

LINC01198

Other Name(s): long intergenic non-protein coding RNA 1198 | Long intergenic non-protein coding RNA 1198

LINC01198: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01198 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a unique structure that consists of a series of intron-exon boundaries and is located between the 5' and 3' ends of the coding gene. LINC01198 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

The drug targeting potential of LINC01198 is high due to its unique structure and various functions. One of the key features of LINC01198 is its ability to form a stable RNA-protein complex, which can lead to its potential as a drug target. The RNA-protein complex formed by LINC01198 can be targeted by small molecules, antibodies, or other therapeutic agents that are designed to interact with the protein component of the complex.

Another potential mechanism by which LINC01198 can be targeted is its role in cell adhesion. LINC01198 has been shown to play a role in the regulation of cell-cell adhesion, which is essential for various physiological processes, including tissue repair and regeneration. Therefore, small molecules or antibodies that can disrupt LINC01198's role in cell adhesion could be potential drug targets.

In addition to its role in cell adhesion, LINC01198 has also been shown to be involved in the regulation of cell migration. LINC01198 has been shown to play a role in the regulation of cell migration, which is essential for the development and maintenance of tissues and organs. Therefore, small molecules or antibodies that can disrupt LINC01198's role in cell migration could also be potential drug targets.

Biomarker Potential

The biomarker potential of LINC01198 is high due to its unique structure and various functions. One of the key features of LINC01198 is its ability to form a stable RNA-protein complex, which can be used as a biomarker for protein interactions. This can be used to detect potential drug targets that interact with the protein component of the LINC01198-protein complex.

Another potential use of LINC01198 as a biomarker is its role in the regulation of cellular processes. LINC01198 has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and transcriptional regulation. Therefore, small molecules or antibodies that can disrupt LINC01198's role in these processes could also be potential biomarkers.

Conclusion

In conclusion, LINC01198 is a long intergenic non-protein-coding RNA that has a unique structure and plays a role in various cellular processes. Its potential as a drug target and biomarker makes it an attractive target for future research. Further studies are needed to fully understand the role of LINC01198 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1198

The "LINC01198 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01198 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets